Keywords:
Performed at one institution, Not applicable, Prospective, Haemorrhage, Arteriosclerosis, Puncture, Arterial access, Angioplasty, Percutaneous, Fluoroscopy, Catheter arteriography, Vascular, Interventional vascular, Arteries / Aorta, Interventional Radiology
Authors:
T. Tsochatzis1, S. C. Spiliopoulos1, G. festas1, L. Reppas1, F. Christidi1, K. Palialexis1, E. Brountzos2; 1Athens/GR, 2Haidari/GR
DOI:
10.26044/ecr2020/C-12253
Purpose
Atherosclerosis in its distinctive manifestations of coronary artery disease, peripheral artery disease (PAD), and cerebrovascular disease constitutes the main cause of morbidity and mortality worldwide.[1] Over the past years, the number of peripheral endovascular procedures to treat symptomatic PAD has been significantly increased not only because of high technical success, low complication rates, and shorter hospitalization time but also because of the percentage of PAD patients with no surgical options or at high surgical risk, mainly due to old age and severe comorbidities.[2-4] In spite of the low rates of complications associated with peripheral endovascular procedures, bleeding events remain the most frequent life-threatening sequelae, occurring in 2.0% to 10.5% of the procedures.[5,6]The HAS-BLED score has been used to assess the bleeding risk profile of patients with symptomatic PAD.[7,8] However, it has not been investigated whether it is effective in predicting bleeding complications in the setting of peripheral endovascular procedures.
This study sought to assess the bleeding complications of peripheral endovascular therapy (EVT) in a real-world population treated in a high-volume vascular center and to develop an easy-to-use, dedicated, preprocedural peripheral bleeding score (PBS) for identifying patients at high risk for periprocedural bleeding events.